Hims & Hers Health (HIMS) Net Margin Growth (1y) (2021 - 2026)

Hims & Hers Health (HIMS) Net Margin Growth (1y) (2021 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin Growth (1y) (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 372.00
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn -82.00
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn -538.00
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -2,930.00
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 2,292.00
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn -146.00
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -2,359.00
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 1,181.00
10 Liquidia 5.64 Bn 5.42 Bn 121.79 Mn 126,951.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -2,359.00
Dec 31, 2025 -207.00
Sep 30, 2025 -1,619.00
Jun 30, 2025 359.00
Mar 31, 2025 444.00
Dec 31, 2024 490.00
Sep 30, 2024 2,216.00
Jun 30, 2024 765.00
Mar 31, 2024 928.00
Dec 31, 2023 703.00
Sep 30, 2023 967.00
Jun 30, 2023 1,389.00
Mar 31, 2023 1,076.00
Dec 31, 2022 3,027.00
Sep 30, 2022 848.00
Jun 30, 2022 -225.00
Mar 31, 2022 8,222.00
Dec 31, 2021 -2,418.00
Sep 30, 2021 -728.00
Jun 30, 2021 -1,235.00